Academic case study on Nav1.9 as a drug target by Associate Professor David Bulmer (University of Cambridge). Overview of Metrion’s newly developed Nav1.9 screening assays by Metrion CSO, Dr. Eddy Stevens.
Studying ion channels on the lysosomal membrane is essential for understanding lysosomal function, cellular homeostasis, and the development of various neurological diseases, such as Parkinson's disease. This research has the potential to uncover new therapeutic targets and improve our knowledge of fundamental cellular processes.
In this video we demonstrate how to perform the lysosomal patch clamp technique to study ion channels on the lysosomal membrane.
We extend our sincere gratitude to Professor Michael Gold and Dr. Anthony M. Rush for sharing their expertise and to all attendees for their engagement and insightful questions. Your participation contributes to ongoing advancements in the field of chronic pain research.
Academic case study on Nav1.9 as a drug target by Associate Professor David Bulmer (University of Cambridge). Overview of Metrion’s newly developed Nav1.9 screening assays by Metrion CSO, Dr. Eddy Stevens.
Alex Haworth, Senior Scientist at Metrion, introduces a poster demonstrating Metrion's development of a monoclonal CHO cell line expressing hNav1.9, validated via manual and automated patch clamp techniques.